Literature DB >> 7688785

Expression of a functional c-kit receptor on a subset of natural killer cells.

M E Matos1, G S Schnier, M S Beecher, L K Ashman, D E William, M A Caligiuri.   

Abstract

Natural killer (NK) cells are large granular lymphocytes thought to be important in the host's early immune response to viral infection and malignant transformation. NK cells proliferate and display enhanced cytotoxic activity in response to the T cell growth factor, interleukin 2 (IL-2). Stem cell factor or steel factor (SF) is the ligand for the c-kit receptor, and when combined with other hematopoietic growth factors, SF synergistically promotes the proliferation and differentiation of bone marrow stem cells. In the present study we show the c-kit receptor to be uniquely expressed on a subset of resting human NK cells (CD56bright) which constitutively expresses both the high affinity IL-2 receptor (IL-2R) and the intermediate affinity IL-2R. Other lymphocyte populations, including CD56dim NK cells, did not appear to express the c-kit receptor. Within the CD56bright NK cell subset, SF alone had no obvious effect on proliferation or cytotoxic activity. SF was shown to significantly augment the proliferative effect of IL-2, and caused a marked shift in the dose-response curve at IL-2 concentrations that selectively saturate the high affinity IL-2R. The potentiating effect of SF on NK cell proliferation was dependent on IL-2 binding to the high affinity IL-2R, and was blocked by a monoclonal antibody directed against the c-kit receptor. SF did not enhance proliferation at higher IL-2 concentrations that saturate the intermediate affinity IL-2R, nor did SF enhance IL-2-induced cytotoxic activity. Together, these data indicate that SF and IL-2 act synergistically to directly augment the proliferative capacity of a unique human NK cell subset constitutively expressing the high affinity IL-2R and the c-kit receptor. The implications of these findings on NK cell development and the host's early immune response to pathogen invasion are discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7688785      PMCID: PMC2191187          DOI: 10.1084/jem.178.3.1079

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  18 in total

Review 1.  Biology and clinical relevance of human natural killer cells.

Authors:  M J Robertson; J Ritz
Journal:  Blood       Date:  1990-12-15       Impact factor: 22.113

2.  Identification of a ligand for the c-kit proto-oncogene.

Authors:  D E Williams; J Eisenman; A Baird; C Rauch; K Van Ness; C J March; L S Park; U Martin; D Y Mochizuki; H S Boswell
Journal:  Cell       Date:  1990-10-05       Impact factor: 41.582

3.  Erythropoietin receptor and interleukin-2 receptor beta chain: a new receptor family.

Authors:  A D D'Andrea; G D Fasman; H F Lodish
Journal:  Cell       Date:  1989-09-22       Impact factor: 41.582

4.  Identification, purification, and biological characterization of hematopoietic stem cell factor from buffalo rat liver--conditioned medium.

Authors:  K M Zsebo; J Wypych; I K McNiece; H S Lu; K A Smith; S B Karkare; R K Sachdev; V N Yuschenkoff; N C Birkett; L R Williams
Journal:  Cell       Date:  1990-10-05       Impact factor: 41.582

5.  Comparative studies of human FcRIII-positive and negative natural killer cells.

Authors:  A Nagler; L L Lanier; S Cwirla; J H Phillips
Journal:  J Immunol       Date:  1989-11-15       Impact factor: 5.422

6.  Recombinant human stem cell factor synergises with GM-CSF, G-CSF, IL-3 and epo to stimulate human progenitor cells of the myeloid and erythroid lineages.

Authors:  I K McNiece; K E Langley; K M Zsebo
Journal:  Exp Hematol       Date:  1991-03       Impact factor: 3.084

7.  Constitutive expression of high affinity interleukin 2 receptors on human CD16-natural killer cells in vivo.

Authors:  A Nagler; L L Lanier; J H Phillips
Journal:  J Exp Med       Date:  1990-05-01       Impact factor: 14.307

8.  Soluble stem cell factor in human serum.

Authors:  K E Langley; L G Bennett; J Wypych; S A Yancik; X D Liu; K R Westcott; D G Chang; K A Smith; K M Zsebo
Journal:  Blood       Date:  1993-02-01       Impact factor: 22.113

9.  Functional consequences of interleukin 2 receptor expression on resting human lymphocytes. Identification of a novel natural killer cell subset with high affinity receptors.

Authors:  M A Caligiuri; A Zmuidzinas; T J Manley; H Levine; K A Smith; J Ritz
Journal:  J Exp Med       Date:  1990-05-01       Impact factor: 14.307

10.  The interleukin 2 receptor. Functional consequences of its bimolecular structure.

Authors:  H M Wang; K A Smith
Journal:  J Exp Med       Date:  1987-10-01       Impact factor: 14.307

View more
  33 in total

1.  Potential mechanisms of human natural killer cell expansion in vivo during low-dose IL-2 therapy.

Authors:  T A Fehniger; E M Bluman; M M Porter; E Mrózek; M A Cooper; J B VanDeusen; S R Frankel; W Stock; M A Caligiuri
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

Review 2.  Generation of natural killer cells from hematopoietic stem cells in vitro for immunotherapy.

Authors:  Martha Luevano; Alejandro Madrigal; Aurore Saudemont
Journal:  Cell Mol Immunol       Date:  2012-06-18       Impact factor: 11.530

Review 3.  Molecular characterization of CD34+ human hematopoietic progenitor cells.

Authors:  W Knapp; H Strobl; C Scheinecker; C Bello-Fernandez; O Majdic
Journal:  Ann Hematol       Date:  1995-06       Impact factor: 3.673

4.  CD56 Expression Marks Human Group 2 Innate Lymphoid Cell Divergence from a Shared NK Cell and Group 3 Innate Lymphoid Cell Developmental Pathway.

Authors:  Luxi Chen; Youssef Youssef; Cameron Robinson; Gabrielle F Ernst; Mary Y Carson; Karen A Young; Steven D Scoville; Xiaoli Zhang; Regine Harris; Palak Sekhri; Anthony G Mansour; Wing K Chan; Ansel P Nalin; Hsiaoyin C Mao; Tiffany Hughes; Emily M Mace; Yinghong Pan; Navin Rustagi; Sujash S Chatterjee; Preethi H Gunaratne; Gregory K Behbehani; Bethany L Mundy-Bosse; Michael A Caligiuri; Aharon G Freud
Journal:  Immunity       Date:  2018-09-04       Impact factor: 31.745

Review 5.  Signaling of c-kit in dendritic cells influences adaptive immunity.

Authors:  Prabir Ray; Nandini Krishnamoorthy; Timothy B Oriss; Anuradha Ray
Journal:  Ann N Y Acad Sci       Date:  2010-01       Impact factor: 5.691

6.  A potential role for interleukin-15 in the regulation of human natural killer cell survival.

Authors:  W E Carson; T A Fehniger; S Haldar; K Eckhert; M J Lindemann; C F Lai; C M Croce; H Baumann; M A Caligiuri
Journal:  J Clin Invest       Date:  1997-03-01       Impact factor: 14.808

Review 7.  Natural killer cell neoplasm: biology and pathology.

Authors:  Maria Francisca Ham; Young-Hyeh Ko
Journal:  Int J Hematol       Date:  2010-12-07       Impact factor: 2.490

8.  NK1.1+ cells and IL-22 regulate vaccine-induced protective immunity against challenge with Mycobacterium tuberculosis.

Authors:  Rohan Dhiman; Sivakumar Periasamy; Peter F Barnes; Ankita Garg Jaiswal; Padmaja Paidipally; Amanda B Barnes; Amy Tvinnereim; Ramakrishna Vankayalapati
Journal:  J Immunol       Date:  2012-06-18       Impact factor: 5.422

9.  Human natural killer cells produce abundant macrophage inflammatory protein-1 alpha in response to monocyte-derived cytokines.

Authors:  E M Bluman; K J Bartynski; B R Avalos; M A Caligiuri
Journal:  J Clin Invest       Date:  1996-06-15       Impact factor: 14.808

10.  Mouse fetal and embryonic liver cells differentiate human umbilical cord blood progenitors into CD56-negative natural killer cell precursors in the absence of interleukin-15.

Authors:  Valarie McCullar; Robert Oostendorp; Angela Panoskaltsis-Mortari; Gong Yun; Charles T Lutz; John E Wagner; Jeffrey S Miller
Journal:  Exp Hematol       Date:  2008-03-04       Impact factor: 3.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.